(Q53313817)

13 May 2018

title

The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies. (English)

1 reference

13 May 2018

1 reference

1 reference

1

1 reference

13 May 2018

Cristina Santos

3

1 reference

13 May 2018

Eduardo Tolosa

4

object named as

Eduardo Tolosa

1 reference

13 May 2018

author name string

Montserrat Domingo-Sàbat

2

1 reference

13 May 2018

Isidro Ferrer

5

1 reference

13 May 2018

Aurelio Ariza

6

1 reference

13 May 2018

language of work or name

English

0 references

publication date

19 October 2010

1 reference

13 May 2018

published in

Brain

1 reference

13 May 2018

volume

133

1 reference

13 May 2018

issue

Pt 12

1 reference

13 May 2018

page(s)

3724-3733

1 reference

13 May 2018

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Diagnostic criteria for neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Cognitive dysfunction and dementia in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Beta-synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

A critical reappraisal of current staging of Lewy-related pathology in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Striatal beta-amyloid deposition in Parkinson disease with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Beta-synuclein gene alterations in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Effect of RNA quality on transcript intensity levels in microarray analysis of human post-mortem brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Mathematics of quantitative kinetic PCR and the application of standard curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Residual structure, backbone dynamics, and interactions within the synuclein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ275

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWQ275

1 reference

13 May 2018

1 reference

13 May 2018